AU2021321433A1 - Heteroaryl and heterocyclyl compounds - Google Patents
Heteroaryl and heterocyclyl compounds Download PDFInfo
- Publication number
- AU2021321433A1 AU2021321433A1 AU2021321433A AU2021321433A AU2021321433A1 AU 2021321433 A1 AU2021321433 A1 AU 2021321433A1 AU 2021321433 A AU2021321433 A AU 2021321433A AU 2021321433 A AU2021321433 A AU 2021321433A AU 2021321433 A1 AU2021321433 A1 AU 2021321433A1
- Authority
- AU
- Australia
- Prior art keywords
- compound
- alkyl
- heteroalkyl
- halogen
- haloalkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/541—Non-condensed thiazines containing further heterocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/06—Peri-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063060968P | 2020-08-04 | 2020-08-04 | |
| US63/060,968 | 2020-08-04 | ||
| PCT/US2021/044564 WO2022031862A2 (en) | 2020-08-04 | 2021-08-04 | Heteroaryl and heterocyclyl compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2021321433A1 true AU2021321433A1 (en) | 2023-03-02 |
Family
ID=80120142
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2021321433A Pending AU2021321433A1 (en) | 2020-08-04 | 2021-08-04 | Heteroaryl and heterocyclyl compounds |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230303502A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4192468A4 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2023536633A (cg-RX-API-DMAC10.html) |
| KR (1) | KR20230048523A (cg-RX-API-DMAC10.html) |
| CN (1) | CN116322777A (cg-RX-API-DMAC10.html) |
| AU (1) | AU2021321433A1 (cg-RX-API-DMAC10.html) |
| BR (1) | BR112023002132A2 (cg-RX-API-DMAC10.html) |
| CA (1) | CA3190778A1 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2022031862A2 (cg-RX-API-DMAC10.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4531879A1 (en) | 2022-05-25 | 2025-04-09 | Flagship Pioneering Innovations VI, LLC | Compositions of secretory and/or catalytic cells and methods using the same |
| JP2025520113A (ja) | 2022-06-03 | 2025-07-01 | フラッグシップ パイオニアリング イノベーションズ シックス,エルエルシー | 組成物及び方法 |
| IL328729A (en) | 2023-12-01 | 2026-07-01 | Sigilon Therapeutics Inc | Methods for producing stem cell-derived islet-like cells, as well as populations and compositions comprising them |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2411197A (en) * | 1996-04-30 | 1997-11-19 | Affymax Technologies N.V. | Methods for the synthesis of fmoc protected amines |
| CN103819403B (zh) * | 2008-12-31 | 2017-01-04 | 阿德利克斯公司 | 用于治疗与体液潴留或盐超负荷有关的病症和胃肠道病症的化合物和方法 |
| ES3036749T3 (en) * | 2014-08-01 | 2025-09-23 | Massachusetts Inst Technology | Modified alginates for anti-fibrotic materials and applications |
| EP3215519A1 (en) * | 2014-11-06 | 2017-09-13 | Novartis AG | Amatoxin derivatives and conjugates thereof as inhibitors of rna polymerase |
| US20180185368A1 (en) * | 2014-11-06 | 2018-07-05 | Lysosomal Therapeutics Inc. | Substituted pyrrolo[1,2-a]pyrimidines and their use in the treatment of medical disorders |
| CR20180229A (es) * | 2015-10-29 | 2018-08-24 | Novartis Ag | Conjugados de anticuerpos que comprenden un agonista del receptor tipo toll |
| KR20230156818A (ko) * | 2016-10-03 | 2023-11-14 | 시질론 테라퓨틱스, 인크. | 화합물, 장치, 및 이의 용도 |
| IL315310A (en) * | 2017-12-26 | 2024-10-01 | Kymera Therapeutics Inc | Irak degraders and uses thereof |
| CN112203646A (zh) * | 2018-04-04 | 2021-01-08 | 西吉隆医疗股份有限公司 | 可植入颗粒和相关方法 |
-
2021
- 2021-08-04 CA CA3190778A patent/CA3190778A1/en active Pending
- 2021-08-04 US US18/019,664 patent/US20230303502A1/en active Pending
- 2021-08-04 BR BR112023002132A patent/BR112023002132A2/pt unknown
- 2021-08-04 CN CN202180068241.8A patent/CN116322777A/zh active Pending
- 2021-08-04 AU AU2021321433A patent/AU2021321433A1/en active Pending
- 2021-08-04 WO PCT/US2021/044564 patent/WO2022031862A2/en not_active Ceased
- 2021-08-04 JP JP2023507667A patent/JP2023536633A/ja active Pending
- 2021-08-04 KR KR1020237007667A patent/KR20230048523A/ko active Pending
- 2021-08-04 EP EP21854105.0A patent/EP4192468A4/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2023536633A (ja) | 2023-08-28 |
| WO2022031862A2 (en) | 2022-02-10 |
| BR112023002132A2 (pt) | 2023-04-11 |
| KR20230048523A (ko) | 2023-04-11 |
| US20230303502A1 (en) | 2023-09-28 |
| EP4192468A4 (en) | 2024-09-11 |
| WO2022031862A3 (en) | 2022-03-24 |
| CA3190778A1 (en) | 2022-02-10 |
| EP4192468A2 (en) | 2023-06-14 |
| CN116322777A (zh) | 2023-06-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4192468A2 (en) | Heteroaryl and heterocyclyl compounds | |
| WO2023275301A1 (en) | Imidazotriazine derivatives as il-17 modulators | |
| AU2017266325B2 (en) | Imidazoles as histone demethylase inhibitors | |
| EP3990451A1 (en) | Fused imidazole derivatives as il-17 modulators | |
| AU2013243353B2 (en) | Fused cyclopentyl antagonists of CCR2 | |
| CN119866336A (zh) | 毒蕈碱受体激动剂的结晶形式和盐 | |
| EP4132650A1 (en) | Difluorocyclohexyl derivatives as il-17 modulators | |
| EP4069702A1 (en) | Sstr5 antagonists | |
| WO2023250107A1 (en) | Process for preparing modulators of eukaryotic initiation factor 2b | |
| AU2024226158A1 (en) | Solid formulations and polymorphic forms of indoline inhibitors of kif18a | |
| JP6940480B2 (ja) | Fgfr阻害剤の合成方法 | |
| AU2022273544B2 (en) | Methods of making a modulator of hemoglobin | |
| KR20240148351A (ko) | 브루톤 티로신 키나제 억제제의 합성 | |
| JP2025525622A (ja) | Il-17モジュレーターとしてのイミダゾトリアジン誘導体 | |
| ES2977277T3 (es) | Procesos para preparar (3R,4R)-1-bencil-n,4-dimetilpiperidin-3-amina o una de sus sales y procesos para preparar tofacitinib mediante el uso de la misma | |
| KR20260052982A (ko) | Pi3k 억제제의 제조 방법 | |
| WO2025008574A1 (en) | 2-phenoxy-1-(4-(alkylsulfonyl)piperidin-1-yl)ethan-1-one and 3-phenyl-1-(4-(alkylsulfonyl)piperidin-1-yl)prop-2-en-1-one derivatives as gpr183 antagonists for the treatment of chronic pain | |
| AU2022240650B2 (en) | Estrogen receptor antagonist | |
| WO2018109271A1 (en) | New bromodomain inhibitors | |
| WO2025149985A1 (en) | Methods of preparing melanocortin 4 receptor agonists | |
| ES2279093T3 (es) | Procedimiento para preparar derivados imidazolicos y sus sales. | |
| WO2017108927A1 (en) | Process for preparation of ingenol 3-(3.5-diethylisoxazole-4-carboxylate) | |
| CN118715228A (zh) | 布鲁顿酪氨酸激酶抑制剂的合成 | |
| Savage et al. | ASYMMETRIC SYNTHESIS OF A HOMOCHIRAL A2-ISOXAZOLINE AMINO ACID DERIVATIVE |